We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00327600
Recruitment Status : Completed
First Posted : May 18, 2006
Last Update Posted : September 15, 2010
Sponsor:
Information provided by:
AmpliMed Corporation